BVBirgitta Katinka Velthuis

Birgitta Katinka Velthuis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Birgitta Katinka Velthuis has a total of 502 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Feasibility of Continuous Ventricular Volumetric Quantification in Arrhythmias using Real-Time 3D CMR-MOTUS

    by Thomas Edi Olausson, Maarten Lennart Terpstra, Rizwan Ahmad, Edwin Versteeg, Casper Beijst, Yuchi Han, Marco Guglielmo, Birgitta Katinka Velthuis, Cornelis van Den Berg, Alessandro Sbrizzi

  • Open Access

    Sport Type Alone Does Not Reliably Predict Distinct Cardiac Phenotypes in Athletes

    by Maarten A van Diepen, Niek H J Prakken, Stephan van der Zwaard, Joelle J N Daems, Hiba el Hri, Bastiaan J Adema, S Matthijs Boekholdt, Adrienne van Randen, Ronald J Walhout, Suzanna T de Vries, et al.

    Aims: : Sport-type classification frameworks recommended by European (ESC) and American (AHA/ACC) guidelines are used to contextualize cardiac remodelling in athletes but remain unvalidated against cardiac magnetic resonance (CMR) phenotypes. We aimed to evaluate whether sport classifications predict CMR-determined cardiac remodelling phenotypes in elite athletes. Methods and Results: : We included 1,024 individuals: 775 elite athletes (310 women, 48 disciplines) and 249 controls. Athletes were classified by the ESC (four-category) and AHA/ACC (static–dynamic, four-quadrant) frameworks. CMR metrics were transformed to sex-specific z-scores (remodelling: z≥1.645). Because no CMR convention defines geometric phenotypes in athletes, the most strongly associated CMR metric was used to define each framework's assumed phenotype. Performance was evaluated at population (R2) and individual (balanced accuracy) levels. ESC categories were most strongly associated with RVEDV (R2=0.170); RV remodelling prevalence increased from skill to endurance (8.3%–62.2%; OR 3.82 per category; P<0.001). The AHA/ACC static component was most strongly associated with LV mass (R2=0.077) and the dynamic component with RVEDV (R2=0.072). Individual-level discrimination was poor: balanced accuracy was 34.2% (ESC) and 37.7% (AHA/ACC) (vs 25% chance). LV mass and RVEDV showed coupled increases (R2=0.23), with 67% of athletes demonstrating concordant patterns rather than discrete static or dynamic phenotypes. Misclassification was most pronounced for predominantly high-static athletes, of whom 73.8% showed normal geometry rather than expected LV hypertrophy (17.5%). Conclusions: : ESC and AHA/ACC sport classifications capture population-level remodelling but cannot reliably be used to predict individual cardiac phenotypes. In individual athletes interpretation should prioritise observed mass-volume relationships and the overall clinical context rather than sport type alone.


  • Open Access

    Sex-specific redistribution of the hypertrophic cardiomyopathy grey zone in elite athletes using demographic-based wall thickness thresholds

    by Maarten A van Diepen, Joelle J N Daems, Hiba el Hri, S M Boekholdt, Adrienne van Randen, Luuk H G A Hopman, Birgitta K Velthuis, Alexander Hirsch, Nick R Bijsterveld, Harald T Jørstad


  • The TopCoW Challenge — Topology-Aware Circle of Willis Segmentation for CT and MR Angiography

    by Kaiyuan Yang, Fabio Musio, Yihui Ma, Norman Juchler, Johannes C. Paetzold, Rami Al-Maskari, Luciano Höher, Hongwei Bran Li, Ibrahim Ethem Hamamci, Anjany Sekuboyina, et al.


  • Open Access

    Objective Assessment of a Step Artifact Correction Algorithm in Sequential Coronary CT Angiography on Dual-Layer CT

    by Lennart R. Koetzier, Philip M. Tetteroo, Eran Langzam, Dominika Suchá, Niels R. van der Werf, Birgitta K. Velthuis

    Prospectively ECG-triggered sequential coronary CT angiography (CCTA) is prone to step artifacts between cardiac segments imaged during different heartbeats, which can obscure plaque and impair automated tools such as CT-fractional flow reserve. We evaluated a vendor-specific step artifact reduction (SAR) algorithm, alone and combined with motion-compensated reconstruction (MCR), in sequential CCTA. We retrospectively analyzed 79 patients scanned on a 128-slice dual-layer spectral CT system. Reconstructions compared were clinical standard, SAR, and SAR+MCR. Lumen continuity across the step interface in the left anterior descending (LAD) and right coronary arteries (RCA) was quantified by the Jaccard index (JI), and whole-heart continuity by histogram entropy of subtraction images; Cohen d is reported for effect sizes. Across 165 coronary step segments, SAR increased mean JI from 0.38 to 0.58 (+0.20; 95% CI: 0.16-0.23; P d =0.84), similar in both vessels (LAD +0.20, d =0.82; RCA +0.19, d =0.87). Entropy decreased from 3.81 to 3.51 (−0.30; P d =−3.12), indicating fewer step-related structures. In 25 motion-affected RCA segments, SAR alone increased the JI from 0.35 to 0.49, and adding MCR raised it to 0.70 (+0.22 vs. SAR alone; P d =0.89). SAR improved vessel and whole-heart continuity on dual-layer spectral CT, with additional benefit from MCR in motion-affected segments.

  • Left Ventricular Late Gadolinium Enhancement for Arrhythmic Risk Prediction in ARVC

    by Corrado De Marco, Babken Asatryan, Anneline S.J.M. Te Riele, Andrea Di Marco, Alessio Gasperetti, Antoine Delinière, Jason D. Roberts, Henrik K. Jensen, Brianna Davies, Andrew D. Krahn, et al.

    BACKGROUND: The arrhythmogenic right ventricular cardiomyopathy (ARVC) risk calculator estimates the risk of incident sustained ventricular arrhythmia (VA) and performs well in ARVC populations meeting 2010 Task Force Criteria. However, the calculator includes no measure of left ventricular (LV) structure and function, while late gadolinium enhancement (LGE) on cardiac magnetic resonance shows promise in arrhythmic risk prediction. This study aims to evaluate whether LV LGE on cardiac magnetic resonance can further refine ARVC VA risk stratification. METHODS: Patients with definite ARVC, no prior sustained VA, and contrast-enhanced cardiac magnetic resonance at baseline were followed at 17 centers. Survival analyses were performed to assess LV LGE effect on VA prediction, and its incremental prognostic value on the risk calculator was evaluated using Cox proportional hazard models. The presence of high-risk LGE, defined as LV epicardial, transmural, or combined septal and free-wall LGE, was studied as a sensitivity analysis. RESULTS: Of 385 patients (39.6±15.4 years, 39.7% male, 54.0% probands), 132 (34.3%) had LV LGE on cardiac magnetic resonance, with 98 (25.5%) having a high-risk pattern. Over 3.1 [1.2–5.8] years of follow-up, 67 (17.4%) patients experienced VA. In univariable analysis, both LV LGE (hazard ratio, 1.82; P =0.014) and high-risk LV LGE (hazard ratio, 1.85; P =0.017) were associated with higher risk for VA. However, after adjusting for the ARVC calculator–estimated risk, the presence of neither LV LGE ( P =0.85) nor high-risk LV LGE ( P =0.87) independently predicted sustained VA. (graphic abstract) CONCLUSIONS: While associated with the risk of VA in ARVC, LV LGE did not provide incremental prognostic value for incident VA risk prediction compared with the ARVC risk calculator.


  • Open Access

    Coronary calcium scoring on contrast‐enhanced spectral coronary computed tomography angiography using a calcium‐specific algorithm

    by L. R. Koetzier, P. M. Tetteroo, E. Encinas Vargas, A. M. R. Schilham, M. J. W. Greuter, E. Langzam, B. K. Velthuis, D. Suchá, N. R. van der Werf

    Background: Coronary artery calcium (CAC) scoring requires a non‐contrast scan in addition to contrast‐enhanced coronary CT angiography (CCTA), increasing radiation dose and scan time. Virtual non contrast (VNC) methods from spectral CT may obviate the CAC CT scan, but available methods underestimate CAC scores and show low detectability. Although VNC‐based CAC scoring is feasible via conversion factors, it misses low‐density calcifications, requiring improved VNC methods. Purpose: This study evaluates a self‐developed CAC‐preserving VNC (TrueCa) method to improve detectability and quantification of CAC on CCTA. Methods: An artificial hollow coronary artery containing five cylindrical calcifications of varying density calcium hydroxyapatite (75–800 mg/cc) was filled with 0%, 50%, 100% (400 Hounsfield units) and 150% of a clinical iodine concentration. The phantom was scanned on dual‐layer spectral CT with a CAC scoring and CCTA protocol with five repetitions. CAC CT reconstruction followed Agatston protocol. CCTA scans were reconstructed at thick (3 mm) and thin (0.67 mm) slices using (1) commercially available VNC and (2) self‐developed TrueCa algorithm, generated via linear separation of spectral data. Non‐overlapping 95% confidence intervals between Agatston scores (AS) from the CAC protocol and CCTA protocol indicated significant differences. Volume scores (VS) were compared to physical calcification volume. Results: For AS, thick‐slice VNC CCTA underestimated AS by 30%–65% across all CAC densities, failing to detect CAC below 400 mg/cc. TrueCa CCTA detected all calcifications without significant difference with CAC CT for all CAC densities. Thin‐slice compared to thick‐slice TrueCa significantly increased AS in low‐density CAC. For VS, TrueCa CCTA showed less underestimation than VNC CCTA across all densities except for highest‐density calcifications. VS accuracy improved by up to 40% using TrueCa over VNC in medium to lowest‐density calcifications. Conclusion: In this phantom study, TrueCa CCTA demonstrated superior performance in calcium detection and quantification across most CAC densities, showing potential as a reliable alternative to CAC CT.


  • Open Access

    Cardiac Ventricular Hinge Point LGE Is Highly Prevalent and Sex-Dependent in ELITE Athletes

    by Sjoerd M. Verwijs, Juliette C. Van Hattum, Joëlle J.N. Daems, S. Matthijs Boekholdt, R. Nils Planken, Maarten Groenink, Adrienne van Randen, Raschel D. van Luijk, Jules L. Nelissen, Maarten H. Moen, et al.

    BACKGROUND: Myocardial late gadolinium enhancement (LGE) using cardiac magnetic resonance imaging has been described in older endurance athletes, particularly at the ventricular hinge point. However, data on young, elite athletes are lacking. We therefore quantified the prevalence of hinge point LGE (HP-LGE) in young elite-level athletes. METHODS: We investigated 309 (40% women; median age 25.1 [21.9–29.5] years) asymptomatic athletes included in the ELITE prospective cohort (Evaluation of Lifetime Participation in Intensive Top-level Sports and Exercise cohort), investigating cardiovascular screenings of elite (national-, international-, Olympic-, or Paralympic-) level athletes, including cardiac magnetic resonance imaging with short-axis cine imaging, LGE, and T1-mapping. RESULTS: A total of 124 (40%) athletes had HP-LGE, with a higher prevalence in men compared with women (47% versus 30%; P =0.004). When indexed for body surface area, athletes with HP-LGE had greater left ventricle end-systolic volumes (53±11 mL/m² versus 51±11 mL/m²; P =0.037), right ventricle end-systolic volumes (56±12 mL/m² versus 53±11 mL/m²; P =0.020), lower left ventricle ejection fraction (55.5±5.0% versus 56.7±4.6%; P =0.035), lower right ventricle ejection fraction (53.9±5.0% versus 55.2±4.4%; P =0.021), and smaller estimated global left ventricle extracellular volumes (24.45±2.52% versus 25.27±2.59%; P =0.015). In multivariable regression analyses, male sex was strongly associated with HP-LGE (odds ratio, 3.07 [95% CI, 1.32–7.32]; P =0.010). CONCLUSIONS: HP-LGE is a common finding in asymptomatic, elite athletes and is strongly associated with sex. Lower left ventricle ejection fraction is moderately associated with HP-LGE. Our study’s HP-LGE prevalence indicates that HP-LGE should be interpreted as a feature of the athlete’s heart.


  • Optimizing coronary CT angiography with spectral dual-layer CT: motion-compensated virtual monoenergetic imaging achieves 50% contrast dose reduction in a phantom study

    by E. Encinas Vargas, P. M. Tetteroo, C. H. Kristiansen, M. M. Dobrolinska, M. J. W. Greuter, M. Vembar, M. Grass, T. Leiner, B. K. Velthuis, N. R. van der Werf, et al.

    Reduced contrast media (CM) dose at elevated heart rates (HRs) poses a challenge for coronary artery disease (CAD) assessment. Using a dynamic phantom, we evaluated the performance of a vendor-specific coronary motion-compensated reconstruction (MCR) at various simulated HRs and reduced CM dose in low virtual monoenergetic images (VMIs) from coronary computed tomography angiography (CCTA). A clinical CCTA protocol was used to image a 5-mm artificial coronary artery, filled with 100% (400 Hounsfield units (HU)) and 50% CM dose, using a robotic arm for translation at six velocities (0–50 mm/s, 10 mm/s steps). Conventional images and VMIs (40–70 keV, 10 keV steps) were reconstructed without and with MCR. The study evaluated the MCR influence on motion area and contrast-to-noise ratio (CNR) of the resulting segmented arteries (motion area), with the static conventional reconstructed artery at 100% CM dose as the reference, and non-overlapping 95% confidence intervals with the reference indicating significant differences. At 50% CM dose, motion area increased significantly (up to 50%) at elevated velocities (≥ 30 mm/s) without MCR, while no significant variations were observed with MCR. Additionally, without MCR, VMIs exhibited significant CNR decreases (up to 65%) at velocities ≥ 30 mm/s. Only the combination of MCR and 40 keV VMI achieved CNR comparable to the reference, regardless of HR. The combination of MCR with low VMIs enables 50% CM dose reduction, with similar motion area and CNR when compared to conventional CCTA with 100% CM dose. These parameter settings can potentially be used to optimize low CM dose CCTA at higher HRs. Graphical abstract


  • Open Access

    Arterial stiffness and atherosclerosis and incident cardiovascular events and all‐cause mortality in individuals with manifest cardiovascular disease with and without type 2 diabetes

    by Jan F. de Leijer, Frank L. J. Visseren, Birgitta K. Velthuis, Ynte M. Ruigrok, Jaco J.M. Zwanenburg, Manon G. van der Meer, Martin Teraa, Pim A. de Jong, Thomas T. van Sloten, the UCC‐SMART study group

    Background: It is unclear if arterial stiffness and atherosclerosis are differentially related to cardiovascular events and mortality in individuals with manifest cardiovascular disease with and without type 2 diabetes (T2DM) and to what extent they mediate the relation between T2DM and these outcomes.Methods: Prospective data were used from the UCC‐SMART cohort, including individuals with manifest cardiovascular disease (n = 9465). Arterial stiffness (brachial pulse pressure and carotid artery distensibility coefficient (DC)) and atherosclerosis (presence of carotid plaque and ankle‐brachial index <0.9) were determined. Cardiovascular events included non‐fatal stroke, non‐fatal myocardial infarction and cardiovascular death. Cox regression and structural equation models were used with adjustment for confounders.Results: Over a median follow‐up of 10.3 years, 2087 cardiovascular events and 2808 deaths occurred. Higher brachial pulse pressure was related to cardiovascular events and mortality in individuals with T2DM and without T2DM (HRs ≥ 1.09; 95% confidence intervals (CIs) between 1.03 and 1.30). Lower carotid artery DC was related to mortality in individuals with T2DM and without T2DM (hazard ratios (HRs) ≥ 1.20; 95% CI between 1.00 and 1.48), but only related to cardiovascular events in individuals without T2DM (HR 1.34; 95% CI between 1.20 and 1.49). Carotid and lower extremity atherosclerosis were both related to cardiovascular events and mortality in individuals with T2DM and without T2DM (HRs ≥ 1.52; 95% CI between 1.27 and 2.21). Up to 8.1% and 16.3% of the relation between T2DM and outcomes was mediated through arterial stiffness and atherosclerosis, respectively.Conclusion: Arterial stiffness and atherosclerosis are independently, but not differentially, related to cardiovascular events and mortality in individuals with manifest cardiovascular disease with and without T2DM. Atherosclerosis explained a larger proportion of the relation between T2DM and outcomes.